Literature DB >> 11832771

Allelic loss on chromosomes 8 and 9 correlates with clinical outcome in locally advanced clear cell carcinoma of the kidney.

Joseph C Presti1, Monica Wilhelm, Victor Reuter, Paul Russo, Robert Motzer, Frederic Waldman.   

Abstract

PURPOSE: We correlated allelic loss on chromosomes 8p, 9p and 14q with clinical outcome in locally advanced conventional renal cell carcinoma.
MATERIALS AND METHODS: We analyzed radical nephrectomy specimens from 72 stage P3N0 conventional renal cell carcinomas by microsatellite loss of heterozygosity (LOH) analyses directed at chromosomes 3p, 8p, 9p and 14q (2 primers per chromosome). All patients were treated with surgery only. LOH results were correlated with disease-free survival using the Kaplan-Meier method.
RESULTS: We detected LOH on chromosome 3p in 60 of 64 (94%), on chromosome 8p in 19 of 59 (32%), on 9p in 21 of 67 (31%) and on 14q in 18 of 70 (26%) informative cases. Of the 72 patients 24 (33%) had recurrence during followup. On univariate analysis patients with tumors demonstrating LOH on chromosomes 8p and 9q were at high risk for recurrence (p = 0.01). The correlation of recurrence with LOH approached significance for the individual chromosomes 8p and 9p (p = 0.10 and 0.14, respectively). No correlation was observed of LOH on chromosome 14q with recurrence (p = 0.42). The correlation of tumor grade with risk of relapse also approached significance (p = 0.12). On multivariate analysis LOH on chromosome 8p was a more powerful predictor of recurrence than tumor grade. When combinations of LOH on chromosomes were tested, LOH on chromosomes 8p and 9p was the most powerful predictor of recurrence (p = 0.006).
CONCLUSIONS: LOH on chromosomes 8p or 9p may provide prognostic significance in patients with locally advanced renal cell carcinoma.

Entities:  

Mesh:

Year:  2002        PMID: 11832771

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

1.  Advances of multidetector computed tomography in the characterization and staging of renal cell carcinoma.

Authors:  Athina C Tsili; Maria I Argyropoulou
Journal:  World J Radiol       Date:  2015-06-28

Review 2.  A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss.

Authors:  Vincenzo Di Nunno; Veronica Mollica; Matteo Brunelli; Lidia Gatto; Riccardo Schiavina; Michelangelo Fiorentino; Matteo Santoni; Rodolfo Montironi; Anna Caliò; Albino Eccher; Michele Milella; Guido Martignoni; Eugenio Brunocilla; Francesco Massari
Journal:  Mol Diagn Ther       Date:  2019-10       Impact factor: 4.074

Review 3.  Classical pathology versus molecular pathology in renal cell carcinoma.

Authors:  Peggy Soung Sullivan; JianYu Rao; Liang Cheng; Richard J Cote
Journal:  Curr Urol Rep       Date:  2007-01       Impact factor: 3.092

Review 4.  Cancer and forensic microsatellites.

Authors:  Karen Page; Eleanor A M Graham
Journal:  Forensic Sci Med Pathol       Date:  2008-02-02       Impact factor: 2.007

5.  Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array.

Authors:  Marieta I Toma; Marianne Grosser; Alexander Herr; Daniela E Aust; Axel Meye; Christian Hoefling; Susanne Fuessel; Daniela Wuttig; Manfred P Wirth; Gustavo B Baretton
Journal:  Neoplasia       Date:  2008-07       Impact factor: 5.715

6.  Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma.

Authors:  A Ari Hakimi; Roy Mano; Giovanni Ciriello; Mithat Gonen; Nina Mikkilineni; John P Sfakianos; Philip H Kim; Robert J Motzer; Paul Russo; Victor E Reuter; James J Hsieh; Irina Ostrovnaya
Journal:  J Urol       Date:  2014-02-08       Impact factor: 7.450

Review 7.  Significance of chromosome 9p status in renal cell carcinoma: a systematic review and quality of the reported studies.

Authors:  Ismail El-Mokadem; John Fitzpatrick; Bhavan Rai; J Cunningham; Norman Pratt; Stewart Fleming; Ghulam Nabi
Journal:  Biomed Res Int       Date:  2014-04-30       Impact factor: 3.411

8.  Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery.

Authors:  I El-Mokadem; J Fitzpatrick; J Bondad; P Rauchhaus; J Cunningham; N Pratt; S Fleming; G Nabi
Journal:  Br J Cancer       Date:  2014-08-19       Impact factor: 7.640

9.  Oncocytoma-like renal tumor with transformation toward high-grade oncocytic carcinoma: a unique case with morphologic, immunohistochemical, and genomic characterization.

Authors:  Sahussapont J Sirintrapun; Kim R Geisinger; Adela Cimic; Anthony Snow; Jill Hagenkord; Federico Monzon; Benjamin L Legendre; Anatole Ghazalpour; Ryan P Bender; Zoran Gatalica
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

Review 10.  Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms.

Authors:  Ning Yi Yap; Retnagowri Rajandram; Keng Lim Ng; Jayalakshmi Pailoor; Ahmad Fadzli; Glenda Carolyn Gobe
Journal:  Biomed Res Int       Date:  2015-09-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.